{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T19:01:24Z","timestamp":1794078084109,"version":"4.8.0"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T00:00:00Z","timestamp":1648080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T00:00:00Z","timestamp":1648080000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA163772"],"award-info":[{"award-number":["R01CA163772"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA196521"],"award-info":[{"award-number":["P30CA196521"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL130826"],"award-info":[{"award-number":["R01HL130826"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute"},{"DOI":"10.13039\/100012636","name":"New York State Stem Cell Science","doi-asserted-by":"publisher","award":["IIRP 20"],"award-info":[{"award-number":["IIRP 20"]}],"id":[{"id":"10.13039\/100012636","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Here we focus on the molecular characterization of clinically significant histological subtypes of early-stage lung adenocarcinoma (esLUAD), which is the most common histological subtype of lung cancer. Within lung adenocarcinoma, histology is heterogeneous and associated with tumor invasion and diverse clinical outcomes. We present a gene signature distinguishing invasive and non-invasive tumors among esLUAD. Using the gene signatures, we estimate an Invasiveness Score that is strongly associated with survival of esLUAD patients in multiple independent cohorts and with the invasiveness phenotype in lung cancer cell lines. Regulatory network analysis identifies aurora kinase as one of master regulators of the gene signature and the perturbation of aurora kinases in vitro and in a murine model of invasive lung adenocarcinoma reduces tumor invasion. Our study reveals aurora kinases as a therapeutic target for treatment of early-stage invasive lung adenocarcinoma.<\/jats:p>","DOI":"10.1038\/s41467-022-29230-7","type":"journal-article","created":{"date-parts":[[2022,3,25]],"date-time":"2022-03-25T07:36:15Z","timestamp":1648193775000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Integrative network analysis of early-stage lung adenocarcinoma identifies aurora kinase inhibition as interceptor of invasion and progression"],"prefix":"10.1038","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5616-2293","authenticated-orcid":false,"given":"Seungyeul","family":"Yoo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhilasha","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9754-9945","authenticated-orcid":false,"given":"Nasser K.","family":"Altorki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9250-5978","authenticated-orcid":false,"given":"Radhika","family":"Tandon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deebly","family":"Chavez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunjee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4959-5397","authenticated-orcid":false,"given":"Ayushi S.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2338-1665","authenticated-orcid":false,"given":"Takashi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranran","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bisen","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric E.","family":"Schadt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6017-6361","authenticated-orcid":false,"given":"Hideo","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre P.","family":"Massion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6807-8064","authenticated-orcid":false,"given":"Alain C.","family":"Borczuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0834-8178","authenticated-orcid":false,"given":"Jun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3509-891X","authenticated-orcid":false,"given":"Charles A.","family":"Powell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,24]]},"reference":[{"key":"29230_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209\u2013249 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"29230_CR2","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1056\/NEJMoa1916623","volume":"383","author":"N Howlader","year":"2020","unstructured":"Howlader, N. et al. The effect of advances in lung-cancer treatment on population mortality. N. Engl. J. Med. 383, 640\u2013649 (2020).","journal-title":"N. Engl. J. Med."},{"key":"29230_CR3","first-page":"242","volume":"3","author":"H Uramoto","year":"2014","unstructured":"Uramoto, H. & Tanaka, F. Recurrence after surgery in patients with NSCLC. Transl. Lung Cancer Res. 3, 242\u2013249 (2014).","journal-title":"Transl. Lung Cancer Res."},{"key":"29230_CR4","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1164\/rccm.200504-615OC","volume":"172","author":"AC Borczuk","year":"2005","unstructured":"Borczuk, A. C., Kim, H. K., Yegen, H. A., Friedman, R. A. & Powell, C. A. Lung adenocarcinoma global profiling identifies type II transforming growth factor-beta receptor as a repressor of invasiveness. Am. J. Respir. Crit. Care Med. 172, 729\u2013737 (2005).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"29230_CR5","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1097\/JTO.0b013e318206a221","volume":"6","author":"WD Travis","year":"2011","unstructured":"Travis, W. D. et al. International association for the study of lung cancer\/American thoracic society\/European respiratory society international multidisciplinary classification of lung adenocarcinoma. J. Thorac. Oncol. 6, 244\u2013285 (2011).","journal-title":"J. Thorac. Oncol."},{"key":"29230_CR6","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646\u2013674 (2011).","journal-title":"Cell"},{"key":"29230_CR7","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.cels.2017.10.014","volume":"5","author":"KH Yu","year":"2017","unstructured":"Yu, K. H. et al. Association of omics features with histopathology patterns in lung adenocarcinoma. Cell Syst. 5, 620\u2013627.e623 (2017).","journal-title":"Cell Syst."},{"key":"29230_CR8","doi-asserted-by":"crossref","unstructured":"Xing, X. et al. Decoding the multicellular ecosystem of lung adenocarcinoma manifested as pulmonary subsolid nodules by single-cell RNA sequencing. Sci. Adv. 7, eabd9738 (2021).","DOI":"10.1126\/sciadv.abd9738"},{"key":"29230_CR9","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1097\/JTO.0b013e3181c8cc0c","volume":"5","author":"RL Toonkel","year":"2010","unstructured":"Toonkel, R. L., Borczuk, A. C. & Powell, C. A. Tgf-beta signaling pathway in lung adenocarcinoma invasion. J. Thorac. Oncol. 5, 153\u2013157 (2010).","journal-title":"J. Thorac. Oncol."},{"key":"29230_CR10","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1002\/cncr.25768","volume":"117","author":"ML Wilgus","year":"2011","unstructured":"Wilgus, M. L. et al. Lysyl oxidase: a lung adenocarcinoma biomarker of invasion and survival. Cancer 117, 2186\u20132191 (2011).","journal-title":"Cancer"},{"key":"29230_CR11","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.lungcan.2013.07.025","volume":"82","author":"LA Pikor","year":"2013","unstructured":"Pikor, L. A., Ramnarine, V. R., Lam, S. & Lam, W. L. Genetic alterations defining NSCLC subtypes and their therapeutic implications. Lung Cancer 82, 179\u2013189 (2013).","journal-title":"Lung Cancer"},{"key":"29230_CR12","doi-asserted-by":"publisher","first-page":"708","DOI":"10.3390\/cancers14030708","volume":"14","author":"A Sinha","year":"2022","unstructured":"Sinha, A. et al. Early-stage lung adenocarcinoma MDM2 genomic amplification predicts clinical outcome and response to targeted therapy. Cancers 14, 708 (2022).","journal-title":"Cancers"},{"key":"29230_CR13","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1164\/rccm.202108-1985ED","volume":"204","author":"CA Powell","year":"2021","unstructured":"Powell, C. A. In case of invasive nodule, break ground glass. Am. J. Respir. Crit. Care Med. 204, 1124\u20131126 (2021).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"29230_CR14","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1083\/jcb.200802005","volume":"182","author":"AW Bird","year":"2008","unstructured":"Bird, A. W. & Hyman, A. A. Building a spindle of the correct length in human cells requires the interaction between TPX2 and Aurora A. J. Cell Biol. 182, 289\u2013300 (2008).","journal-title":"J. Cell Biol."},{"key":"29230_CR15","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1242\/jcs.037259","volume":"122","author":"DK Moss","year":"2009","unstructured":"Moss, D. K., Wilde, A. & Lane, J. D. Dynamic release of nuclear RanGTP triggers TPX2-dependent microtubule assembly during the apoptotic execution phase. J. Cell Sci. 122, 644\u2013655 (2009).","journal-title":"J. Cell Sci."},{"key":"29230_CR16","doi-asserted-by":"publisher","first-page":"2987","DOI":"10.1242\/jcs.013136","volume":"120","author":"AR Barr","year":"2007","unstructured":"Barr, A. R. & Gergely, F. Aurora-A: the maker and breaker of spindle poles. J. Cell Sci. 120, 2987\u20132996 (2007).","journal-title":"J. Cell Sci."},{"key":"29230_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00209-z","volume":"8","author":"RL Shrestha","year":"2017","unstructured":"Shrestha, R. L. et al. Aurora-B kinase pathway controls the lateral to end-on conversion of kinetochore-microtubule attachments in human cells. Nat. Commun. 8, 150 (2017).","journal-title":"Nat. Commun."},{"key":"29230_CR18","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/onc.2012.628","volume":"33","author":"AB D\u2019Assoro","year":"2014","unstructured":"D\u2019Assoro, A. B. et al. The mitotic kinase Aurora-a promotes distant metastases by inducing epithelial-to-mesenchymal transition in ERalpha(+) breast cancer cells. Oncogene 33, 599\u2013610 (2014).","journal-title":"Oncogene"},{"key":"29230_CR19","first-page":"991","volume":"9","author":"D Li","year":"2003","unstructured":"Li, D. et al. Overexpression of oncogenic STK15\/BTAK\/Aurora A kinase in human pancreatic cancer. Clin. Cancer Res. 9, 991\u2013997 (2003).","journal-title":"Clin. Cancer Res."},{"key":"29230_CR20","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"29230_CR21","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon, A. et al. The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell Syst. 1, 417\u2013425 (2015).","journal-title":"Cell Syst."},{"key":"29230_CR22","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/nm.1790","volume":"14","author":"Director\u2019s Challenge Consortium for the Molecular Classification of Lung, A.","year":"2008","unstructured":"Director\u2019s Challenge Consortium for the Molecular Classification of Lung, A. et al. Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study. Nat. Med. 14, 822\u2013827 (2008).","journal-title":"Nat. Med."},{"key":"29230_CR23","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nm1243","volume":"11","author":"I Poola","year":"2005","unstructured":"Poola, I. et al. Identification of MMP-1 as a putative breast cancer predictive marker by global gene expression analysis. Nat. Med. 11, 481\u2013483 (2005).","journal-title":"Nat. Med."},{"key":"29230_CR24","doi-asserted-by":"publisher","first-page":"3170","DOI":"10.1038\/sj.onc.1209083","volume":"25","author":"J Gotzmann","year":"2006","unstructured":"Gotzmann, J. et al. A crucial function of PDGF in TGF-beta-mediated cancer progression of hepatocytes. Oncogene 25, 3170\u20133185 (2006).","journal-title":"Oncogene"},{"key":"29230_CR25","doi-asserted-by":"publisher","first-page":"7155","DOI":"10.1038\/sj.onc.1206887","volume":"22","author":"M Jechlinger","year":"2003","unstructured":"Jechlinger, M. et al. Expression profiling of epithelial plasticity in tumor progression. Oncogene 22, 7155\u20137169 (2003).","journal-title":"Oncogene"},{"key":"29230_CR26","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1158\/0008-5472.CAN-07-2017","volume":"68","author":"D Sarrio","year":"2008","unstructured":"Sarrio, D. et al. Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype. Cancer Res. 68, 989\u2013997 (2008).","journal-title":"Cancer Res."},{"key":"29230_CR27","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1158\/1078-0432.CCR-06-1820","volume":"13","author":"J Jaeger","year":"2007","unstructured":"Jaeger, J. et al. Gene expression signatures for tumor progression, tumor subtype, and tumor thickness in laser-microdissected melanoma tissues. Clin. Cancer Res. 13, 806\u2013815 (2007).","journal-title":"Clin. Cancer Res."},{"key":"29230_CR28","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1158\/1078-0432.CCR-05-0835","volume":"12","author":"MA Bidus","year":"2006","unstructured":"Bidus, M. A. et al. Prediction of lymph node metastasis in patients with endometrioid endometrial cancer using expression microarray. Clin. Cancer Res 12, 83\u201388 (2006).","journal-title":"Clin. Cancer Res"},{"key":"29230_CR29","doi-asserted-by":"publisher","first-page":"5578","DOI":"10.1038\/onc.2008.168","volume":"27","author":"YL Liao","year":"2008","unstructured":"Liao, Y. L. et al. Identification of SOX4 target genes using phylogenetic footprinting-based prediction from expression microarrays suggests that overexpression of SOX4 potentiates metastasis in hepatocellular carcinoma. Oncogene 27, 5578\u20135589 (2008).","journal-title":"Oncogene"},{"key":"29230_CR30","doi-asserted-by":"publisher","first-page":"241","DOI":"10.18632\/oncotarget.6280","volume":"7","author":"Z Lu","year":"2016","unstructured":"Lu, Z. et al. Long non-coding RNA HULC promotes tumor angiogenesis in liver cancer by up-regulating sphingosine kinase 1 (SPHK1). Oncotarget 7, 241\u2013254 (2016).","journal-title":"Oncotarget"},{"key":"29230_CR31","doi-asserted-by":"publisher","first-page":"4042","DOI":"10.1158\/0008-5472.CAN-06-3321","volume":"67","author":"RJ Vart","year":"2007","unstructured":"Vart, R. J. et al. Kaposi\u2019s sarcoma-associated herpesvirus-encoded interleukin-6 and G-protein-coupled receptor regulate angiopoietin-2 expression in lymphatic endothelial cells. Cancer Res. 67, 4042\u20134051 (2007).","journal-title":"Cancer Res."},{"key":"29230_CR32","doi-asserted-by":"publisher","first-page":"D1023","DOI":"10.1093\/nar\/gkv1268","volume":"44","author":"M Zhao","year":"2016","unstructured":"Zhao, M., Kim, P., Mitra, R., Zhao, J. & Zhao, Z. TSGene 2.0: an updated literature-based knowledgebase for tumor suppressor genes. Nucleic Acids Res. 44, D1023\u2013D1031 (2016).","journal-title":"Nucleic Acids Res."},{"key":"29230_CR33","doi-asserted-by":"publisher","first-page":"10528","DOI":"10.1073\/pnas.0504367102","volume":"102","author":"CF Gao","year":"2005","unstructured":"Gao, C. F. et al. Proliferation and invasion: plasticity in tumor cells. Proc. Natl Acad. Sci. USA 102, 10528\u201310533 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"29230_CR34","doi-asserted-by":"publisher","first-page":"e1002240","DOI":"10.1371\/journal.pcbi.1002240","volume":"7","author":"D Venet","year":"2011","unstructured":"Venet, D., Dumont, J. E. & Detours, V. Most random gene expression signatures are significantly associated with breast cancer outcome. PLoS Comput. Biol. 7, e1002240 (2011).","journal-title":"PLoS Comput. Biol."},{"key":"29230_CR35","doi-asserted-by":"publisher","first-page":"6665","DOI":"10.1158\/0008-5472.CAN-11-1590","volume":"71","author":"AC Borczuk","year":"2011","unstructured":"Borczuk, A. C. et al. Progression of human bronchioloalveolar carcinoma to invasive adenocarcinoma is modeled in a transgenic mouse model of K-ras-induced lung cancer by loss of the TGF-beta type II receptor. Cancer Res. 71, 6665\u20136675 (2011).","journal-title":"Cancer Res."},{"key":"29230_CR36","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/nature11003","volume":"483","author":"J Barretina","year":"2012","unstructured":"Barretina, J. et al. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature 483, 603\u2013607 (2012).","journal-title":"Nature"},{"key":"29230_CR37","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1038\/ng.167","volume":"40","author":"J Zhu","year":"2008","unstructured":"Zhu, J. et al. Integrating large-scale functional genomic data to dissect the complexity of yeast regulatory networks. Nat. Genet. 40, 854\u2013861 (2008).","journal-title":"Nat. Genet."},{"key":"29230_CR38","doi-asserted-by":"publisher","first-page":"e1001301","DOI":"10.1371\/journal.pbio.1001301","volume":"10","author":"J Zhu","year":"2012","unstructured":"Zhu, J. et al. Stitching together multiple data dimensions reveals interacting metabolomic and transcriptomic networks that modulate cell regulation. PLoS Biol. 10, e1001301 (2012).","journal-title":"PLoS Biol."},{"key":"29230_CR39","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/ncb936","volume":"5","author":"MY Tsai","year":"2003","unstructured":"Tsai, M. Y. et al. A Ran signalling pathway mediated by the mitotic kinase Aurora A in spindle assembly. Nat. Cell Biol. 5, 242\u2013248 (2003).","journal-title":"Nat. Cell Biol."},{"key":"29230_CR40","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1093\/annonc\/mdv034","volume":"26","author":"Y Takahashi","year":"2015","unstructured":"Takahashi, Y. et al. The AURKA\/TPX2 axis drives colon tumorigenesis cooperatively with MYC. Ann. Oncol. 26, 935\u2013942 (2015).","journal-title":"Ann. Oncol."},{"key":"29230_CR41","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1158\/1078-0432.CCR-07-2179","volume":"14","author":"O Gautschi","year":"2008","unstructured":"Gautschi, O. et al. Aurora kinases as anticancer drug targets. Clin. Cancer Res. 14, 1639\u20131648 (2008).","journal-title":"Clin. Cancer Res."},{"key":"29230_CR42","doi-asserted-by":"publisher","first-page":"278","DOI":"10.3389\/fonc.2015.00278","volume":"5","author":"V Bavetsias","year":"2015","unstructured":"Bavetsias, V. & Linardopoulos, S. Aurora kinase inhibitors: current status and outlook. Front. Oncol. 5, 278 (2015).","journal-title":"Front. Oncol."},{"key":"29230_CR43","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1016\/j.cell.2017.10.049","volume":"171","author":"A Subramanian","year":"2017","unstructured":"Subramanian, A. et al. A next generation connectivity map: L1000 platform and the first 1,000,000 profiles. Cell 171, 1437\u20131452.e1417 (2017).","journal-title":"Cell"},{"key":"29230_CR44","doi-asserted-by":"publisher","first-page":"3052","DOI":"10.1093\/emboj\/17.11.3052","volume":"17","author":"JR Bischoff","year":"1998","unstructured":"Bischoff, J. R. et al. A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers. EMBO J. 17, 3052\u20133065 (1998).","journal-title":"EMBO J."},{"key":"29230_CR45","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1038\/sj.onc.1201065","volume":"14","author":"S Sen","year":"1997","unstructured":"Sen, S., Zhou, H. & White, R. A. A putative serine\/threonine kinase encoding gene BTAK on chromosome 20q13 is amplified and overexpressed in human breast cancer cell lines. Oncogene 14, 2195\u20132200 (1997).","journal-title":"Oncogene"},{"key":"29230_CR46","first-page":"2041","volume":"59","author":"T Tanaka","year":"1999","unstructured":"Tanaka, T. et al. Centrosomal kinase AIK1 is overexpressed in invasive ductal carcinoma of the breast. Cancer Res. 59, 2041\u20132044 (1999).","journal-title":"Cancer Res."},{"key":"29230_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-10-461","volume":"10","author":"ZZ Lin","year":"2010","unstructured":"Lin, Z. Z. et al. Significance of Aurora B overexpression in hepatocellular carcinoma. Aurora B overexpression in HCC. BMC Cancer 10, 461 (2010).","journal-title":"BMC Cancer"},{"key":"29230_CR48","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.1158\/1535-7163.MCT-06-0301","volume":"5","author":"B Vischioni","year":"2006","unstructured":"Vischioni, B., Oudejans, J. J., Vos, W., Rodriguez, J. A. & Giaccone, G. Frequent overexpression of aurora B kinase, a novel drug target, in non-small cell lung carcinoma patients. Mol. Cancer Ther. 5, 2905\u20132913 (2006).","journal-title":"Mol. Cancer Ther."},{"key":"29230_CR49","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s00428-006-0360-9","volume":"450","author":"G Qi","year":"2007","unstructured":"Qi, G. et al. Aurora-B expression and its correlation with cell proliferation and metastasis in oral cancer. Virchows Arch. 450, 297\u2013302 (2007).","journal-title":"Virchows Arch."},{"key":"29230_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/s13008-018-0040-6","volume":"13","author":"E Willems","year":"2018","unstructured":"Willems, E. et al. The functional diversity of aurora kinases: a comprehensive review. Cell Div. 13, 7 (2018).","journal-title":"Cell Div."},{"key":"29230_CR51","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1002\/ajh.24736","volume":"92","author":"HM Kantarjian","year":"2017","unstructured":"Kantarjian, H. M. et al. A phase 1 study of AMG 900, an orally administered pan-aurora kinase inhibitor, in adult patients with acute myeloid leukemia. Am. J. Hematol. 92, 660\u2013667 (2017).","journal-title":"Am. J. Hematol."},{"key":"29230_CR52","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1007\/s10637-018-0625-6","volume":"36","author":"M Carducci","year":"2018","unstructured":"Carducci, M. et al. A phase 1, first-in-human study of AMG 900, an orally administered pan-aurora kinase inhibitor, in adult patients with advanced solid tumors. Invest. N. Drugs 36, 1060\u20131071 (2018).","journal-title":"Invest. N. Drugs"},{"key":"29230_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-018-1014-y","volume":"20","author":"JR Diamond","year":"2018","unstructured":"Diamond, J. R. et al. A phase II clinical trial of the Aurora and angiogenic kinase inhibitor ENMD-2076 for previously treated, advanced, or metastatic triple-negative breast cancer. Breast Cancer Res. 20, 82 (2018).","journal-title":"Breast Cancer Res."},{"key":"29230_CR54","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1016\/j.ejca.2011.07.008","volume":"47","author":"P Schoffski","year":"2011","unstructured":"Schoffski, P. et al. Phase I, open-label, multicentre, dose-escalation, pharmacokinetic and pharmacodynamic trial of the oral aurora kinase inhibitor PF-03814735 in advanced solid tumours. Eur. J. Cancer 47, 2256\u20132264 (2011).","journal-title":"Eur. J. Cancer"},{"key":"29230_CR55","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1210\/en.2005-1404","volume":"147","author":"HY Zhou","year":"2006","unstructured":"Zhou, H. Y. & Wong, A. S. Activation of p70S6K induces expression of matrix metalloproteinase 9 associated with hepatocyte growth factor-mediated invasion in human ovarian cancer cells. Endocrinology 147, 2557\u20132566 (2006).","journal-title":"Endocrinology"},{"key":"29230_CR56","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1038\/nrm1245","volume":"4","author":"M Carmena","year":"2003","unstructured":"Carmena, M. & Earnshaw, W. C. The cellular geography of aurora kinases. Nat. Rev. Mol. Cell Biol. 4, 842\u2013854 (2003).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"29230_CR57","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.ceb.2009.09.008","volume":"21","author":"M Carmena","year":"2009","unstructured":"Carmena, M., Ruchaud, S. & Earnshaw, W. C. Making the Auroras glow: regulation of Aurora A and B kinase function by interacting proteins. Curr. Opin. Cell Biol. 21, 796\u2013805 (2009).","journal-title":"Curr. Opin. Cell Biol."},{"key":"29230_CR58","doi-asserted-by":"crossref","first-page":"4111","DOI":"10.1242\/jcs.131045","volume":"127","author":"G Wang","year":"2014","unstructured":"Wang, G., Jiang, Q. & Zhang, C. The role of mitotic kinases in coupling the centrosome cycle with the assembly of the mitotic spindle. J. Cell Sci. 127, 4111\u20134122 (2014).","journal-title":"J. Cell Sci."},{"key":"29230_CR59","first-page":"1420","volume":"9","author":"TM Gritsko","year":"2003","unstructured":"Gritsko, T. M. et al. Activation and overexpression of centrosome kinase BTAK\/Aurora-A in human ovarian cancer. Clin. Cancer Res. 9, 1420\u20131426 (2003).","journal-title":"Clin. Cancer Res."},{"key":"29230_CR60","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1023\/B:NEON.0000021784.33421.05","volume":"67","author":"K Araki","year":"2004","unstructured":"Araki, K., Nozaki, K., Ueba, T., Tatsuka, M. & Hashimoto, N. High expression of Aurora-B\/Aurora and Ipll-like midbody-associated protein (AIM-1) in astrocytomas. J. Neurooncol. 67, 53\u201364 (2004).","journal-title":"J. Neurooncol."},{"key":"29230_CR61","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1158\/1541-7786.MCR-11-0416","volume":"10","author":"X Wang","year":"2012","unstructured":"Wang, X. et al. Overexpression of Aurora-A enhances invasion and matrix metalloproteinase-2 expression in esophageal squamous cell carcinoma cells. Mol. Cancer Res. 10, 588\u2013596 (2012).","journal-title":"Mol. Cancer Res."},{"key":"29230_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-02623-1","volume":"7","author":"J-L Xia","year":"2017","unstructured":"Xia, J.-L. et al. Inhibition of AURKA kinase activity suppresses collective invasion in a microfluidic cell culture platform. Sci. Rep. 7, 2973 (2017).","journal-title":"Sci. Rep."},{"key":"29230_CR63","doi-asserted-by":"publisher","first-page":"151","DOI":"10.14740\/wjon1062w","volume":"8","author":"H Zhao","year":"2017","unstructured":"Zhao, H., Owen, S., Davies, E. L., Jiang, W. G. & Martin, T. A. The effect of aurora kinase inhibitor on adhesion and migration in human breast cancer cells and clinical implications. World J. Oncol. 8, 151\u2013161 (2017).","journal-title":"World J. Oncol."},{"key":"29230_CR64","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.3892\/ol.2016.4110","volume":"11","author":"J Wu","year":"2016","unstructured":"Wu, J. et al. AURKA promotes cell migration and invasion of head and neck squamous cell carcinoma through regulation of the AURKA\/Akt\/FAK signaling pathway. Oncol. Lett. 11, 1889\u20131894 (2016).","journal-title":"Oncol. Lett."},{"key":"29230_CR65","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41388-018-0437-3","volume":"38","author":"E Willems","year":"2019","unstructured":"Willems, E. et al. Aurora A plays a dual role in migration and survival of human glioblastoma cells according to the CXCL12 concentration. Oncogene 38, 73\u201387 (2019).","journal-title":"Oncogene"},{"key":"29230_CR66","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.ajpath.2012.10.023","volume":"182","author":"CH Chen","year":"2013","unstructured":"Chen, C. H. et al. Overexpression of Rap-1A indicates a poor prognosis for oral cavity squamous cell carcinoma and promotes tumor cell invasion via Aurora-A modulation. Am. J. Pathol. 182, 516\u2013528 (2013).","journal-title":"Am. J. Pathol."},{"key":"29230_CR67","doi-asserted-by":"publisher","first-page":"3895","DOI":"10.1007\/s13277-014-3032-4","volume":"36","author":"JY He","year":"2015","unstructured":"He, J. Y. et al. Knockdown of Aurora-B alters osteosarcoma cell malignant phenotype via decreasing phosphorylation of VCP and NF-kappaB signaling. Tumour Biol. 36, 3895\u20133902 (2015).","journal-title":"Tumour Biol."},{"key":"29230_CR68","doi-asserted-by":"publisher","first-page":"560","DOI":"10.3892\/etm.2014.1491","volume":"7","author":"XP Zhu","year":"2014","unstructured":"Zhu, X. P. et al. Inhibition of Aurora-B suppresses osteosarcoma cell migration and invasion. Exp. Ther. Med. 7, 560\u2013564 (2014).","journal-title":"Exp. Ther. Med."},{"key":"29230_CR69","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-020-01674-1","volume":"20","author":"X Wu","year":"2020","unstructured":"Wu, X. et al. Aurora-B knockdown inhibits osteosarcoma metastasis by inducing autophagy via the mTOR\/ULK1 pathway. Cancer Cell Int. 20, 575 (2020).","journal-title":"Cancer Cell Int."},{"key":"29230_CR70","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/onc.2017.354","volume":"37","author":"X Zheng","year":"2018","unstructured":"Zheng, X. et al. Aurora-A-mediated phosphorylation of LKB1 compromises LKB1\/AMPK signaling axis to facilitate NSCLC growth and migration. Oncogene 37, 502\u2013511 (2018).","journal-title":"Oncogene"},{"key":"29230_CR71","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.cell.2011.11.016","volume":"147","author":"P Friedl","year":"2011","unstructured":"Friedl, P. & Alexander, S. Cancer invasion and the microenvironment: plasticity and reciprocity. Cell 147, 992\u20131009 (2011).","journal-title":"Cell"},{"key":"29230_CR72","unstructured":"Matej, R., Rohan, Z., Nemejcova, K. & Dundr, P. Molecular pathology of lung cancer in routine diagnostic practice: 2017 update. Cesk Patol. 53, 159\u2013166 (2017)."},{"key":"29230_CR73","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1056\/NEJMoa2027071","volume":"383","author":"YL Wu","year":"2020","unstructured":"Wu, Y. L. et al. Osimertinib in resected EGFR-mutated non-small-cell lung cancer. N. Engl. J. Med. 383, 1711\u20131723 (2020).","journal-title":"N. Engl. J. Med."},{"key":"29230_CR74","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/nprot.2012.016","volume":"7","author":"C Trapnell","year":"2012","unstructured":"Trapnell, C. et al. Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat. Protoc. 7, 562\u2013578 (2012).","journal-title":"Nat. Protoc."},{"key":"29230_CR75","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"29230_CR76","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/nature13385","volume":"511","author":"Cancer Genome Atlas Research, N.","year":"2014","unstructured":"Cancer Genome Atlas Research, N. Comprehensive molecular profiling of lung adenocarcinoma. Nature 511, 543\u2013550 (2014).","journal-title":"Nature"},{"key":"29230_CR77","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1158\/0008-5472.CAN-11-1403","volume":"72","author":"H Okayama","year":"2012","unstructured":"Okayama, H. et al. Identification of genes upregulated in ALK-positive and EGFR\/KRAS\/ALK-negative lung adenocarcinomas. Cancer Res. 72, 100\u2013111 (2012).","journal-title":"Cancer Res."},{"key":"29230_CR78","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1097\/JTO.0000000000000042","volume":"9","author":"SD Der","year":"2014","unstructured":"Der, S. D. et al. Validation of a histology-independent prognostic gene signature for early-stage, non-small-cell lung cancer including stage IA patients. J. Thorac. Oncol. 9, 59\u201364 (2014).","journal-title":"J. Thorac. Oncol."},{"key":"29230_CR79","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1158\/1078-0432.CCR-12-2321","volume":"19","author":"H Tang","year":"2013","unstructured":"Tang, H. et al. A 12-gene set predicts survival benefits from adjuvant chemotherapy in non-small cell lung cancer patients. Clin. Cancer Res. 19, 1577\u20131586 (2013).","journal-title":"Clin. Cancer Res."},{"key":"29230_CR80","doi-asserted-by":"publisher","first-page":"186ra166","DOI":"10.1126\/scitranslmed.3005723","volume":"5","author":"S Rousseaux","year":"2013","unstructured":"Rousseaux, S. et al. Ectopic activation of germline and placental genes identifies aggressive metastasis-prone lung cancers. Sci. Transl. Med. 5, 186ra166 (2013).","journal-title":"Sci. Transl. Med."},{"key":"29230_CR81","doi-asserted-by":"publisher","first-page":"e36530","DOI":"10.1371\/journal.pone.0036530","volume":"7","author":"MD Wilkerson","year":"2012","unstructured":"Wilkerson, M. D. et al. Differential pathogenesis of lung adenocarcinoma subtypes involving sequence mutations, copy number, chromosomal instability, and methylation. PLoS ONE 7, e36530 (2012).","journal-title":"PLoS ONE"},{"key":"29230_CR82","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-015-1465-9","volume":"16","author":"J Das","year":"2015","unstructured":"Das, J., Gayvert, K. M., Bunea, F., Wegkamp, M. H. & Yu, H. ENCAPP: elastic-net-based prognosis prediction and biomarker discovery for human cancers. BMC Genomics 16, 263 (2015).","journal-title":"BMC Genomics"},{"key":"29230_CR83","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/j.1467-9868.2005.00503.x","volume":"67","author":"H Zhu","year":"2005","unstructured":"Zhu, H. & Hastie, T. Regularization and variable selection via the elastic net. J. R. Stat. Soc. Ser. B (Stat. Methodol.) 67, 301\u2013320 (2005).","journal-title":"J. R. Stat. Soc. Ser. B (Stat. Methodol.)"},{"key":"29230_CR84","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.cell.2018.02.052","volume":"173","author":"J Liu","year":"2018","unstructured":"Liu, J. et al. An Integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics. Cell 173, 400\u2013416 e411 (2018).","journal-title":"Cell"},{"key":"29230_CR85","doi-asserted-by":"publisher","first-page":"e1003790","DOI":"10.1371\/journal.pcbi.1003790","volume":"10","author":"S Yoo","year":"2014","unstructured":"Yoo, S. et al. MODMatcher: multi-omics data matcher for integrative genomic analysis. PLoS Comput. Biol. 10, e1003790 (2014).","journal-title":"PLoS Comput. Biol."},{"key":"29230_CR86","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1089\/106652700750050961","volume":"7","author":"N Friedman","year":"2000","unstructured":"Friedman, N., Linial, M., Nachman, I. & Pe\u2019er, D. Using Bayesian networks to analyze expression data. J. Comput. Biol. 7, 601\u2013620 (2000).","journal-title":"J. Comput. Biol."},{"key":"29230_CR87","doi-asserted-by":"publisher","first-page":"e69","DOI":"10.1371\/journal.pcbi.0030069","volume":"3","author":"J Zhu","year":"2007","unstructured":"Zhu, J. et al. Increasing the power to detect causal associations by combining genotypic and expression data in segregating populations. PLoS Comput. Biol. 3, e69 (2007).","journal-title":"PLoS Comput. Biol."},{"key":"29230_CR88","doi-asserted-by":"publisher","first-page":"8 13 11","DOI":"10.1002\/0471250953.bi0813s47","volume":"47","author":"G Su","year":"2014","unstructured":"Su, G., Morris, J. H., Demchak, B. & Bader, G. D. Biological network exploration with Cytoscape 3. Curr. Protoc. Bioinforma. 47, 8 13 11\u201324 (2014).","journal-title":"Curr. Protoc. Bioinforma."},{"key":"29230_CR89","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/msb.2012.24","volume":"8","author":"IM Wang","year":"2012","unstructured":"Wang, I. M. et al. Systems analysis of eleven rodent disease models reveals an inflammatome signature and key drivers. Mol. Syst. Biol. 8, 594 (2012).","journal-title":"Mol. Syst. Biol."},{"key":"29230_CR90","doi-asserted-by":"crossref","unstructured":"Liu, Y. et al. A network analysis of multiple myeloma related gene signatures. Cancers (Basel) 11, 1452(2019).","DOI":"10.3390\/cancers11101452"},{"key":"29230_CR91","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/nm.4306","volume":"23","author":"SM Corsello","year":"2017","unstructured":"Corsello, S. M. et al. The Drug Repurposing Hub: a next-generation drug library and information resource. Nat. Med. 23, 405\u2013408 (2017).","journal-title":"Nat. Med."},{"key":"29230_CR92","doi-asserted-by":"publisher","first-page":"12711","DOI":"10.1073\/pnas.1501597112","volume":"112","author":"AM Brum","year":"2015","unstructured":"Brum, A. M. et al. Connectivity Map-based discovery of parbendazole reveals targetable human osteogenic pathway. Proc. Natl Acad. Sci. USA 112, 12711\u201312716 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"29230_CR93","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1038\/modpathol.2012.211","volume":"26","author":"R Kanagal-Shamanna","year":"2013","unstructured":"Kanagal-Shamanna, R. et al. Differential expression of aurora-A kinase in T-cell lymphomas. Mod. Pathol. 26, 640\u2013647 (2013).","journal-title":"Mod. Pathol."},{"key":"29230_CR94","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/nbt.3437","volume":"34","author":"JG Doench","year":"2016","unstructured":"Doench, J. G. et al. Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9. Nat. Biotechnol. 34, 184\u2013191 (2016).","journal-title":"Nat. Biotechnol."},{"key":"29230_CR95","doi-asserted-by":"publisher","first-page":"9846","DOI":"10.1158\/0008-5472.CAN-10-3001","volume":"70","author":"M Payton","year":"2010","unstructured":"Payton, M. et al. Preclinical evaluation of AMG 900, a novel potent and highly selective pan-aurora kinase inhibitor with activity in taxane-resistant tumor cell lines. Cancer Res. 70, 9846\u20139854 (2010).","journal-title":"Cancer Res."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-29230-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-29230-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-29230-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T11:32:58Z","timestamp":1669289578000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-29230-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,24]]},"references-count":95,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["29230"],"URL":"https:\/\/doi.org\/10.1038\/s41467-022-29230-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-334210\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,24]]},"assertion":[{"value":"31 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.Y., E.L., E.E.S., and J.Z. are employees of Sema4, a for-profit organization that promotes personalized patient care through information-driven insights. C.A.P. reports consulting fees from Astra Zeneca, BMS, Daiichi Sankyo, and Ethicon outside the submitted work. Other authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1592"}}